Product Information
ICOSAPENT ETHYL 1 GRAM CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.4408 per EA under NDC 43598026704. Its NADAC has been published 274 times since Jul 7, 2021.
FDA first approved this application on Aug 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598026704
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ICOSAPENT ETHYLApproval Type
Generic (ANDA)
FDA Application
ANDA209499FDA Approved
8/7/2020
TE Code
AB
On Market Since
6/21/2021
Price Statistics
The NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has been published 274 times since Jul 7, 2021, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4408 per EA |
|---|---|
| All-time high | $2.3347 (Sep 15, 2021) |
| All-time low | $0.4408 (Sep 23, 2026) |
| 52-week high | $0.5153 |
| 52-week low | $0.4408 |
| Median price | $1.2280 |
| Average price | $1.2294 |
| Largest weekly change | +35.6% (Aug 21, 2024) |
| Weeks tracked | 274 |
| Tracking since | Jul 7, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Icosapent Ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Icosapent Ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ICOSAPENT ETHYL 1 GRAM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 1 GRAM CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $0.4408 per EA (NDC 43598026704), effective Sep 30, 2026.
How has the price of ICOSAPENT ETHYL 1 GRAM CAPSULE changed over time?
Over the history we have for it, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has declined 79.9%. It has been tracked across 274 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 1 GRAM CAPSULE?
Since Jul 7, 2021, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has ranged from a low of $0.4408 (Sep 23, 2026) to a high of $2.3347 (Sep 15, 2021), with a median of $1.2280 per EA.
Are there cheaper alternatives to ICOSAPENT ETHYL 1 GRAM CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ICOSAPENT ETHYL 1 GRAM CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ICOSAPENT ETHYL 1 GRAM CAPSULE?
ICOSAPENT ETHYL 1 GRAM CAPSULE (NDC 43598026704) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.